Denmark· DK-28106028517
Dutasterid "Alkaloid"
A dutasteride product containing dutasterid, registered in Denmark by Alkaloid - INT d.o.o.. The same ATC class is registered in 18 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Dutasteride is registered in 18 of 19 countries.
Countries holding a registration under ATC G04CB02 (dutasteride), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 11 of them publish a price we can compare per daily dose
Dutasteride · ATC G04CB02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dutasteride costs, country by country.
Normalised to the WHO defined daily dose (0.5 mg), the median price runs from $0.27 in France to $0.80 in Switzerland — a ×2.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dutasteride · price per daily dose (0.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.80
- ES Spain$0.76
- IT Italy$0.32
- FR France$0.27
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- DUTASTERID
- Manufacturer
- Alkaloid - INT d.o.o.
- Country
- Denmark (DK)
- ATC code
- G04CB02
- ATC class
- Dutasteride
- Defined daily dose
- 0.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106028517
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
178 interactions on record for dutasteride.
Graded by severity as the source publishes them — 66 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dutasteride · interactions on record
178 records
- 66 moderate
- 112 info
Most severe, free to view
- ClotrimazoleA01AB18moderate
- CimetidineA02BA01moderate
- AprepitantA04AD12moderate
- MiconazoleA07AC01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G04CB02
Dutasteride, as other registers publish it.
- CanadaACT DUTASTERIDETEVA CANADA LIMITED
- PolandAdadutAdamed Pharma S.A.
- CzechiaADADUTAdamed Pharma S.A., Czosnów
- CzechiaADADUTAdamed Pharma S.A., Czosnów
- CzechiaADADUTAdamed Pharma S.A., Czosnów
- CzechiaADADUTAdamed Pharma S.A., Czosnów
- CzechiaADADUTAdamed Pharma S.A., Czosnów
- CanadaAPO-DUTASTERIDEAPOTEX INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2b40324-6ea1-430c-add0-0f58fd730001 GET /v1/drugs/e2b40324-6ea1-430c-add0-0f58fd730001?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "kapsler, bløde",
"source": "dkma",
"strength": "0,5 mg",
"auth_role": "RMS",
"dk_drugid": "28106028517",
"substance": "DUTASTERID",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "43369"
}See everything about dutasteride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.